Source: Annual Congress 2002 - Tuberculosis management -1
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. H. Alenova, G. B. Rakishev, A. T. Ismailova (Almaty, Kazakhstan). New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions. Eur Respir J 2002; 20: Suppl. 38, 2276

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness of implementation of lasolvan for comprehensive treatment of new cases with pulmonary TB Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008 Effectiveness of implementation of lasolvan for comprehensive treatment of new cases with pulmonary TB Source: Eur Respir J 2007; 30: Suppl. 51, 658s Year: 2007 The effectiveness of the treatment of patients with TB in the condition adapted DOTS-strategy in Ukraine Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008 Outcomes of DOTS and DOTS Plus regimens implementing among patients with pulmonary tuberculosis relapses Source: Eur Respir J 2002; 20: Suppl. 38, 369s Year: 2002 The efficiency of treatment of new cases of pulmonary TB in the hospital setting Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001 Surgical treatment of first found pulmonary tuberculosis at ineffectiveness of DOTS therapy Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions Year: 2011 Monitoring results of diagnostics and treatment of new TB patients in Uliyanovsk region Source: Annual Congress 2010 - Global tuberculosis control Year: 2010 The standardised treatment of pulmonary TB: outcomes, problems and suggestions Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties Year: 2005 Treatment patients with pulmonary tuberculosis (PT) and accompanying pathologies by DOTS strategy Source: Eur Respir J 2005; 26: Suppl. 49, 192s Year: 2005 Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 New methodologogic approaches to the management of antituberculous service Source: Eur Respir J 2003; 22: Suppl. 45, 381s Year: 2003 Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 Monitoring of new pulmonary TB patients: detection and treatment Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Challenges in TB treatment in children Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Treatment outcomes of new cases of polyresistant pulmonary TB with second line anti-TB drugs in DOTS-Plus regimen Source: Eur Respir J 2002; 20: Suppl. 38, 359s Year: 2002 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Use of molecular-genetic methods in diagnostics and therapy of a tuberculosis (TB) at patients with HIV Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010